Stay updated with breaking news from Caredx Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CareDx (NASDAQ:CDNA – Get Free Report) and Aclarion (NASDAQ:ACON – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, valuation, dividends and risk. Earnings and Valuation This table compares CareDx and Aclarion’s […]
Royce & Associates LP raised its holdings in CareDx, Inc (NASDAQ:CDNA – Free Report) by 332.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 432,505 shares of the company’s stock after purchasing an additional 332,400 shares during the quarter. Royce & Associates LP’s […]
BRISBANE, Calif., August 31, 2023--CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the Company will participate in the H.C. Wainwright 25th Annual Global Investment Conference.
Should the recent bill entitled the Patent Eligibility Restoration Act of 2023 become law, it would override the existing jurisprudence and redefine which inventions are eligible for patenting...
Should the recent bill entitled the Patent Eligibility Restoration Act of 2023 (PERA) become law, it would override the existing jurisprudence and redefine which inventions are eligible...